07:00 , Apr 20, 2009 |  BC Week In Review  |  Clinical News

Diadep: Pilot trial started

Biocortech began a French pilot trial to evaluate Diadep in 12 HCV patients with no history of depression or mood disorders and who will be treated for the first time with Copegus ribavirin and Pegasys...
08:00 , Dec 11, 2006 |  BC Week In Review  |  Company News

Biocortech, Servier deal

Servier and Biocortech partnered to discover and develop compounds to treat neuropsychiatric disorders. Under the three-year deal, Biocortech will provide undisclosed targets and Servier will be responsible for development, regulatory work and commercialization. Biocortech will...
08:00 , Feb 27, 2006 |  BC Week In Review  |  Company News

Biocortech SAS, Columbia University deal

Biocortech and the university partnered to study how differential mRNA editing of the serotonin (5-HT2C) receptor affects depression. The deal combines Biocortech's technology for generating editing profiles of the receptor with the university's CNS tissue...